Search Result "PF299804."
Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli
Diagnosis and New Treatment Modalities for Glioblastoma: Do They Improve Patient Survival?
Journal: Current Molecular Medicine
Volume: 16 Issue: 5 Year: 2016 Page: 447-464
Author(s): R. Alcedo-Guardia,E. Labat,D. Blas-Boria,P.E. Vivas-Mejia
To Investigate Growth Factor Receptor Targets and Generate CancerTargeting Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 30 Year: 2023 Page: 2877-2972
Author(s):
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and New Therapeutic Perspectives in Non Small Cell Lung Cancer
Journal: Current Drug Targets
Volume: 12 Issue: 6 Year: 2011 Page: 922-933
Author(s): Laura Bonanno, Antonio Jirillo, Adolfo Favaretto
Pitfalls in Lung Cancer Molecular Pathology: How to Limit them in Routine Practice?
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 16 Year: 2012 Page: 2638-2651
Author(s): M. Ilie,P. Hofman
HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007